> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Bayer’s Kyleena Intrauterine Device
- URL: https://www.fdaweb.com/fda-approves-bayers-kyleena-intrauterine-device/
- Published: 2016-09-19T12:00:00.000Z
- Updated: 2026-09-14T21:32:57.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5136851

FDA has approved Bayer’s Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a progestin-containing intrauterine system for preventing pregnancy for up to five years. Kyleena is a small, flexible plastic T-shaped device containing levonorgestrel 19.5 mg. It is placed by a healthcare provider during an in-office visit. “Because Kyleena slowly releases levonorgestrel into a woman’s uterus, only small amounts of the hormone enter the blood,” Bayer says.

Approval was based on data from a clinical trial that enrolled 1,452 women who received Kyleena. The device’s year one efficacy was based on two pregnancies and the cumulative five-year efficacy rate was based on 13 pregnancies, the company says. About 71% of 163 women who desired pregnancy after study discontinuation and provided follow-up information conceived within 12 months after device removal.